Pharma Bio Serv Stock Debt To Equity
| PBSV Stock | USD 0.53 0.03 6.00% |
Pharma Bio Serv fundamentals help investors to digest information that contributes to Pharma-Bio Serv's financial success or failures. It also enables traders to predict the movement of Pharma-Bio OTC Stock. The fundamental analysis module provides a way to measure Pharma-Bio Serv's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharma-Bio Serv otc stock.
Pharma-Bio |
Pharma Bio Serv OTC Stock Debt To Equity Analysis
Pharma-Bio Serv's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Pharma-Bio Serv Debt To Equity | 0.03 % |
Most of Pharma-Bio Serv's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharma Bio Serv is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Pharma Bio Serv has a Debt To Equity of 0.032%. This is 99.94% lower than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The debt to equity for all United States stocks is 99.93% higher than that of the company.
Pharma-Bio Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharma-Bio Serv's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Pharma-Bio Serv could also be used in its relative valuation, which is a method of valuing Pharma-Bio Serv by comparing valuation metrics of similar companies.Pharma Bio is currently under evaluation in debt to equity category among its peers.
Pharma-Bio Fundamentals
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 4.87 M | |||
| Shares Outstanding | 22.95 M | |||
| Shares Owned By Insiders | 64.53 % | |||
| Price To Earning | 10.00 X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 0.90 X | |||
| Revenue | 19.4 M | |||
| Gross Profit | 4.88 M | |||
| EBITDA | 1.23 M | |||
| Net Income | 1.01 M | |||
| Cash And Equivalents | 14.24 M | |||
| Cash Per Share | 0.62 X | |||
| Total Debt | 520.77 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 9.07 X | |||
| Book Value Per Share | 0.72 X | |||
| Cash Flow From Operations | 592.46 K | |||
| Earnings Per Share | 0.04 X | |||
| Target Price | 1.77 | |||
| Number Of Employees | 140 | |||
| Beta | 0.36 | |||
| Market Capitalization | 20.88 M | |||
| Total Asset | 20.65 M | |||
| Retained Earnings | 20.5 M | |||
| Working Capital | 20.6 M | |||
| Current Asset | 22.27 M | |||
| Current Liabilities | 1.67 M | |||
| Z Score | 24.0 | |||
| Annual Yield | 0.06 % | |||
| Net Asset | 20.65 M |
About Pharma-Bio Serv Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharma Bio Serv's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharma-Bio Serv using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharma Bio Serv based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharma-Bio OTC Stock Analysis
When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.